Renata Limited
Shoieb Chowdhury Shithil is currently working as a Senior Officer at Renata Limited since July 2021. Prior to this, Shoieb Chowdhury Shithil served as a Commercial Officer at the same company. As an intern, Shoieb Chowdhury Shithil gained experience at The ACME Laboratories Ltd. Shoieb Chowdhury Shithil obtained a Master of Pharmacy-M.Pharm degree from State University of Bangladesh in July 2021, following a Bachelor of Pharmacy - BPharm degree in January 2020 from the same university.
Renata Limited
39 followers
Main Business: Manufacture and Marketing of Human Pharmaceuticals and Animal Therapeutics. We have two production sites. The Mirpur Site is 12 Acres and Rajendrapur Site is 17 Acres. History: The Company started its operations as Pfizer (Bangladesh) Limited in 1972. For the next two decades it continued as a highly successful subsidiary of Pfizer Corporation. However, by the late 1990s the focus of Pfizer had shifted from formulations to research. In accordance with this transformation, Pfizer divested its interests in many countries, including Bangladesh. Specifically, in 1993 Pfizer transferred the ownership of its Bangladesh operations to local shareholders, and the name of the company was changed to Renata Limited. In a gesture of corporate charity, Pfizer donated shares so that, along with a partial payment from the SAJIDA Foundation, 51% ownership of Renata Limited would be held by the Foundation. Today SAJIDA’s microfinance and micro-insurance programs support over 107,120 members and their families; thus far cumulative loan disbursement totals BDT 5,750 million. Currently, SAJIDA’s health program covers over 1 million beneficiaries by delivering services through two 70 bed hospitals, panel doctors in SAJIDA’s micro finance branches, and mobile health teams. To date, the SAJIDA Foundation holds the majority ownership in Renata Limited. To learn more please visit the foundation’s website: www.sajidafoundation.org